JP2012521428A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521428A5 JP2012521428A5 JP2012502097A JP2012502097A JP2012521428A5 JP 2012521428 A5 JP2012521428 A5 JP 2012521428A5 JP 2012502097 A JP2012502097 A JP 2012502097A JP 2012502097 A JP2012502097 A JP 2012502097A JP 2012521428 A5 JP2012521428 A5 JP 2012521428A5
- Authority
- JP
- Japan
- Prior art keywords
- chr
- alkyl
- heterocyclyl
- cycloalkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*1c(c(S)cc(C(N)OC)c2)[n]2c(*)n1 Chemical compound C*1c(c(S)cc(C(N)OC)c2)[n]2c(*)n1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21084509P | 2009-03-23 | 2009-03-23 | |
| US61/210,845 | 2009-03-23 | ||
| PCT/US2010/027286 WO2010111058A1 (en) | 2009-03-23 | 2010-03-15 | P2x3, receptor antagonists for treatment of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012521428A JP2012521428A (ja) | 2012-09-13 |
| JP2012521428A5 true JP2012521428A5 (OSRAM) | 2013-05-02 |
Family
ID=42781385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012502097A Pending JP2012521428A (ja) | 2009-03-23 | 2010-03-15 | 疼痛治療用のｐ２ｘ３受容体アンタゴニスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9238647B2 (OSRAM) |
| EP (1) | EP2410857B1 (OSRAM) |
| JP (1) | JP2012521428A (OSRAM) |
| AU (1) | AU2010229142A1 (OSRAM) |
| CA (1) | CA2755680A1 (OSRAM) |
| WO (1) | WO2010111058A1 (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8946439B2 (en) | 2008-02-29 | 2015-02-03 | Evotec Ag | Amide compounds, compositions and uses thereof |
| US20110237578A1 (en) | 2008-09-18 | 2011-09-29 | Zhi-Liang Wei | Amide compounds, compositions and uses thereof |
| US20100273805A1 (en) * | 2009-04-23 | 2010-10-28 | Astrazeneca Ab | Sulphide bridged derivatives as modulators of mglur5 733 |
| CA2761921A1 (en) * | 2009-06-22 | 2010-12-29 | F. Hoffmann-La Roche Ag | Indole, indazole and benzimidazole arylamides |
| WO2012062751A1 (en) * | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| CN103298810B (zh) * | 2010-11-08 | 2016-03-16 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| HRP20160134T1 (hr) * | 2011-02-25 | 2016-04-08 | Array Biopharma, Inc. | Spojevi triazolopiridina kao inhibitori pim kinaze |
| WO2014117274A1 (en) * | 2013-01-31 | 2014-08-07 | Neomed Institute | Imidazopyridine compounds and uses thereof |
| AU2014365823B2 (en) * | 2013-12-16 | 2019-05-02 | Abs Development 1, Inc. | P2X3 and/or P2X2/3 compounds and methods |
| EP2905282A1 (en) | 2014-02-05 | 2015-08-12 | AXXAM S.p.A. | Substituted thiazole or oxazole as P2X7 receptor antagonists |
| EP3188730B1 (en) | 2014-09-05 | 2019-05-01 | Merck Sharp & Dohme Corp. | Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2 |
| WO2016036633A1 (en) | 2014-09-05 | 2016-03-10 | Merck Sharp & Dohme Corp. | Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2 |
| EP3188731B1 (en) | 2014-09-05 | 2019-04-03 | Merck Sharp & Dohme Corp. | Isoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2 |
| WO2016088838A1 (ja) * | 2014-12-04 | 2016-06-09 | 塩野義製薬株式会社 | プリン誘導体およびその医薬組成物 |
| JO3637B1 (ar) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
| WO2017209267A1 (ja) * | 2016-06-03 | 2017-12-07 | 塩野義製薬株式会社 | プリン誘導体 |
| MA46856A (fr) | 2016-11-18 | 2019-09-25 | Merck Sharp & Dohme | Dérivés d'indazole utiles en tant qu'inhibiteurs de la diacylglycéride o-acyltransférase 2 |
| AU2017360941A1 (en) | 2016-11-18 | 2019-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 |
| KR102606737B1 (ko) * | 2017-03-15 | 2023-11-24 | 스미토모 파마 가부시키가이샤 | 신규 벤즈이미다졸론 화합물 및 그의 의약 용도 |
| TW201932470A (zh) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 具有抗ｒｓｖ活性之吡唑并嘧啶 |
| AU2019216260B2 (en) | 2018-01-31 | 2023-03-02 | Janssen Sciences Ireland Unlimited Company | Cycloalkyl substituted pyrazolopyrimidines having activity against RSV |
| KR20210005569A (ko) | 2018-04-23 | 2021-01-14 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Rsv에 대한 활성을 갖는 헤테로방향족 화합물 |
| EP3971183A4 (en) * | 2019-06-19 | 2022-08-10 | LG Chem, Ltd. | Method for producing indole or indazole compound |
| MX2022009765A (es) * | 2020-02-14 | 2022-09-09 | Bellus Health Cough Inc | Preparacion de un antagonista del purinorreceptor 3 p2x (p2x3). |
| WO2022063205A1 (zh) * | 2020-09-24 | 2022-03-31 | 中国医药研究开发中心有限公司 | 芳基甲酰胺类化合物及其制备方法和医药用途 |
| CN115322143B (zh) * | 2022-07-21 | 2023-07-14 | 安徽德诺医药股份有限公司 | 一种4-哌啶甲酸叔丁酯盐酸盐的制备方法 |
| EP4638420A1 (en) * | 2022-12-20 | 2025-10-29 | Exelixis, Inc. | Compounds that inhibit pkmyt1 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2258728C (en) * | 1996-06-19 | 2011-09-27 | Rhone Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| JP2002523448A (ja) * | 1998-08-28 | 2002-07-30 | サイオス インコーポレイテッド | ｐ３８−αキナーゼのインヒビター |
| CA2381975A1 (en) | 1999-08-19 | 2001-02-22 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| WO2003000682A1 (en) * | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| WO2005070927A2 (en) * | 2004-01-26 | 2005-08-04 | Altana Pharma Ag | 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors |
| WO2007010553A2 (en) | 2005-03-24 | 2007-01-25 | Arrow Coated Products Ltd | Combined multi-layered water soluble film and process for producing the same |
| MX2007013595A (es) | 2005-05-04 | 2008-01-24 | Renovis Inc | Compuestos heterociclicos fusionados y composiciones y usos de estos. |
| MY147756A (en) * | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| US20090054491A1 (en) | 2005-06-28 | 2009-02-26 | Astrazeneca Ab | Use |
| WO2007020194A1 (en) * | 2005-08-15 | 2007-02-22 | F. Hoffmann-La Roche Ag | Piperidine and piperazine derivatives as p2x3 antagonists |
| EP1924264B9 (en) | 2005-09-01 | 2014-02-19 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| EP1934364A4 (en) | 2005-09-30 | 2009-03-25 | Merck & Co Inc | FOR P2X3, A FUNCTIONAL SÜUGER PURINORE CECTOR, CODING NUCLEIC ACIDS, PROCESS FOR THE PREPARATION AND USE THEREOF |
| US8394803B2 (en) * | 2005-11-07 | 2013-03-12 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| WO2007069053A1 (en) * | 2005-12-14 | 2007-06-21 | Pfizer Products Inc. | Benzimidazole antagonists of the h-3 receptor |
| WO2007086080A2 (en) * | 2006-01-30 | 2007-08-02 | Glenmark Pharmaceuticals Limited | NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| EP2592070B1 (en) | 2006-06-29 | 2016-08-31 | F. Hoffmann-La Roche AG | Tetrazole-substituted arylamides |
| FR2903107B1 (fr) * | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| US7563797B2 (en) * | 2006-08-28 | 2009-07-21 | Forest Laboratories Holding Limited | Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands |
| WO2008085302A1 (en) * | 2006-12-20 | 2008-07-17 | Merck & Co., Inc. | Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| EP2134713A2 (en) * | 2006-12-20 | 2009-12-23 | Schering Corporation | Novel jnk inhibitors |
| CA2703915C (en) | 2007-10-31 | 2015-02-24 | Merck Sharp & Dohme Corp. | P2x3 receptor antagonists for treatment of pain |
| US8247401B2 (en) | 2007-10-31 | 2012-08-21 | Merck Sharp & Dohme Corp. | P2X3 receptor antagonists for treatment of pain |
| US8598209B2 (en) | 2008-10-31 | 2013-12-03 | Merck Sharp & Dohme Corp. | P2X3, receptor antagonists for treatment of pain |
| WO2010059836A1 (en) * | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
| CA2761921A1 (en) * | 2009-06-22 | 2010-12-29 | F. Hoffmann-La Roche Ag | Indole, indazole and benzimidazole arylamides |
-
2010
- 2010-03-15 JP JP2012502097A patent/JP2012521428A/ja active Pending
- 2010-03-15 US US13/259,040 patent/US9238647B2/en active Active
- 2010-03-15 EP EP10756586.3A patent/EP2410857B1/en active Active
- 2010-03-15 AU AU2010229142A patent/AU2010229142A1/en not_active Abandoned
- 2010-03-15 WO PCT/US2010/027286 patent/WO2010111058A1/en not_active Ceased
- 2010-03-15 CA CA2755680A patent/CA2755680A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012521428A5 (OSRAM) | ||
| JP2012521429A5 (OSRAM) | ||
| RU2012142180A (ru) | Ингибиторы катехол-о-метилтрансферазы и их применение для лечения психотических расстройств | |
| JP2024153782A (ja) | 多動性運動障害を処置するためのｖｍａｔ２インヒビター | |
| MX2023009222A (es) | Inhibidores tricíclicos-amido-bicíclicos de prmt5. | |
| JP2013521288A5 (OSRAM) | ||
| CA2713025A1 (en) | Kappa selective opioid receptor antagonist | |
| RU2012142171A (ru) | Ингибиторы катехол-о-метилтрансферазы и их применение в лечении психических расстройств | |
| JP2015503507A5 (OSRAM) | ||
| WO2007093624A2 (en) | Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin | |
| RU2014102362A (ru) | Антитромботические соединения | |
| RU2006142521A (ru) | Средство для улучшения когнитивных функций и памяти на основе гидрированных пиридо(4,3-b)индолов (варианты), фармакологическое средство на его основе и способ его применения | |
| EP1858516A1 (en) | Pharmaceutical compositions for the treatment and/or prevention of depression | |
| JP2009541223A5 (OSRAM) | ||
| JP2010535790A5 (OSRAM) | ||
| RU2011137131A (ru) | Производные 1-аминоалкилциклогексана для лечения тиннитуса, связанного с потерей слуха или незначительной потерей слуха | |
| JP2007530694A5 (OSRAM) | ||
| JP2013522368A5 (OSRAM) | ||
| RU2009136592A (ru) | Терапевтические агенты | |
| JP2021505575A5 (OSRAM) | ||
| RU2007120454A (ru) | Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3 | |
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| RU2012108423A (ru) | Ацилгуанидиновые производные с азотсодержащим циклом | |
| JP2017500321A5 (OSRAM) | ||
| JP2017525717A5 (OSRAM) |